Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

News Conference News TCT 2021

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

Todd Neale

November 05, 2021

News Conference News TCT 2021

Failed MitraClip Is Uncommon, but Bleak When It Happens

Michael O'Riordan

October 08, 2021

News Conference News TCT 2020

While Rare, Surgical Removal of TAVR Carries Risks: Global EXPLANT-TAVR Registry

L.A. McKeown

October 21, 2020

News Conference News TCT 2018

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

Michael O'Riordan

September 25, 2018

News Conference News TCT 2015

Companies With Innovative Technologies Compete in TCT Shark Tank

October 13, 2015

Presentation TCT 2013

PCI vs. CABG in Multivessel Disease: Integrating Evidence-Based Medicine with Today's Techniques and Devices for Appropriate Decision Making

Presenter: Marie-Claude Morice

October 29, 2013

$Efficacy and Safety of Bivalirudin Compared to Unfractionated Heparin in Relation to the Use of “Preclose” Technique Using the Perclose Vascular Closure Device Among Patients...$

Presentation TCT 2012

Efficacy and Safety of Bivalirudin Compared to Unfractionated Heparin in Relation to the Use of “Preclose” Technique Using the Perclose Vascular Closure Device Among Patients...

Presenter: Shyam Poludasu, Usman Baber, Chabbra Sandeep, Jennifer Yu, Rebecca Pinnelas, Avery E. Clark, Roxana Mehran, George Dangas, Annapoorna S. Kini, Samin K. Sharma

January 03, 2012

Advertisement

What’s Going to Be Hot at TCT 2025

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

Failed MitraClip Is Uncommon, but Bleak When It Happens

While Rare, Surgical Removal of TAVR Carries Risks: Global EXPLANT-TAVR Registry

PCI vs CABG at 10 Years: MAIN-COMPARE and SYNTAXES Shine Light on Long-term Outcomes

Companies With Innovative Technologies Compete in TCT Shark Tank

PCI vs. CABG in Multivessel Disease: Integrating Evidence-Based Medicine with Today's Techniques and Devices for Appropriate Decision Making

Efficacy and Safety of Bivalirudin Compared to Unfractionated Heparin in Relation to the Use of “Preclose” Technique Using the Perclose Vascular Closure Device Among Patients...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content